Cancer Therapeutics
The overarching goal of the Cancer Therapeutics Program is to foster collaboration across scientific and clinical disciplines in order to gain deeper insights into the underlying causes of cancer and to develop more effective diagnostic, prognostic and therapeutic approaches to cancer. The program brings together translational and clinical researchers, chemists, biologists and biostatisticians who have a focus on projects that will have substantial clinical impact on solid tumors.
Pehr Harbury, PhD
Associate Professor of Biochemistry
Melanie Hayden Gephart, MD, MAS
Professor of Neurosurgery and, by Courtesy, of Neurology
Floyd Holsinger, MD, FACS
Professor of Otolaryngology- Head and Neck Surgery (OHNS)
Brooke Howitt, MD
Associate Professor of Pathology
Amer Karam, MD
Clinical Professor of Obstetrics and Gynecology (Gynecologic Oncology)
Laurence Katznelson, MD
Professor of Neurosurgery and of Medicine (Endocrinology)
Electron Kebebew, MD
Harry A. Oberhelman, Jr. and Mark L. Welton Professor of Surgery (General Surgery)
Saad Khan, MD
Assistant Professor of Medicine (Oncology)
Chaitan Khosla, PhD
Wells H. Rauser and Harold M. Petiprin Professor and Professor of Chemistry and, by Courtesy, of Biochemistry
Jinah Kim, MD, PhD
Assistant Professor of Pathology and of Dermatology
Eric Kool, PhD
George A. and Hilda M. Daubert Professor of Chemistry
Gordon Li, MD
Professor of Neurosurgery and, by Courtesy, of Neurology and of Otolaryngology- Head and Neck Surgery (OHNS)
Douglas Liou, MD
Clinical Assistant Professor of Cardiothoracic Surgery
Anson Lowe, MD
Associate Professor of Medicine (Gastroenterology and Hepatology), Emeritus
Michelle Monje, MD, PhD
Professor of Neurooogy and, by Courtesy, of Neurosurgery, of Pediatrics, of Pathology, and of Psychiatry and Behavioral Sciences
Seema Nagpal, MD
Clinical Associate Professor of Neurology and Neurological Sciences and Clinical Associate Professor, by Courtesy, of Neurosurgery
